Europe Acute Respiratory Distress Syndrome (ARDS) Market - Industry Trends and Forecast to 2029

Market Definition:

Acute respiratory distress syndrome (ARDS) is a life-threatening lung injury that allows fluid to leak into the lungs. Most people who get ARDS are already at the hospital for trauma or illness like COVID-19. The syndrome usually occurs when fluids build up in the tiny, elastic air sacs called alveoli in lungs. This fluid build-up causes less oxygen reach the bloodstream. This deprives the organs to get enough oxygen for their normal function.

People with other illness develops ARDS within few hours to days after the precipitating injury or infection. The risk of death increases with age and depending on severity of illness patients surviving the syndrome becomes hard.  Severe illness or injury which causing damage to the membrane sacs of lungs leads to ARDS. The most common underlying causes for the said diseases includes sepsis, inhalation of harmful substances, severe pneumonia, head, chest or other major injury, coronavirus disease 2019 (COVID-19)  and others.

Market Segmentation:

Europe acute respiratory distress syndrome (ARDS) market is categorized into five notable segments such as cause, type, route of administration, end users and distribution channel.

• On the basis of cause, the Europe acute respiratory distress syndrome (ARDS) market is segmented into coronavirus disease 2019 (COVID-19), sepsis, inhalation of harmful substances, severe pneumonia and others

• On the basis of type, the Europe acute respiratory distress syndrome (ARDS) market is segmented into diagnosis and treatment

• On the basis of route of administration, the Europe acute respiratory distress syndrome (ARDS) market is segmented into oral, parenteral and others

• On the basis of end-users, the Europe acute respiratory distress syndrome (ARDS) market is segmented into hospitals, specialty clinics, home healthcare and others

• On the basis of distribution channel, the Europe acute respiratory distress syndrome (ARDS) market is segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others

Market Players

The key market players for Europe acute respiratory distress syndrome (ARDS) market are listed below:

• Drägerwerk AG & Co. KGaA
• Fisher & Paykel Healthcare Limited.
• LivaNova PLC
• Gilead Sciences, Inc.
• Fresenius SE & Co. KGaA
• Armstrong Medical
• Smiths Medical (part of ICU Medical, Inc.)
• ResMed
• Medtronic
• F. Hoffmann-La Roche Ltd
• Hamilton Medical
• nice Neotech Medical Systems Pvt. Ltd.
• Pfizer Inc.
• WEINMANN Emergency Medical Technology GmbH + Co. KG
• NIPRO
• Terumo Medical Corporation
• Getinge AB.
• EUROSETS and among others.